6912
I. Baglai et al. / Tetrahedron 68 (2012) 6908e6913
crystallographic data for this paper. These data can be obtained free
of charge from The Cambridge Crystallographic Data Centre via
126.8(2s), 128.8(2s), 129.8(2s), 130.0(2s), 130.5(2s), 130.9, 131.4,
132.5, 132.8, 133.1, 133.3, 133.8, 138.6, 139.0, 151.8. UVevis: lmax
(MeOH): 432 nm (
3
¼38,904 L molꢀ1 cmꢀ1). Fluo (lex¼432 nm):
lEm¼497 nm. MS (ESI>0): m/z 416.21 [M]þ; HRMS (ESI>0): m/z
calcd for C29H26N3: 416.2127; found: 416.2119.
6
14
4.3.3. 3-(5,5-Dimethyl-1,3-dioxan-2-yl)-2-phenyl-2,3-dihydro-1H-
Chemical formula
M (g molꢀ1
C
29H26ClN3
C19H21NO2
295.38
Triclinic
P-1
8.8753(4)
10.0547(4)
10.6142(4)
64.768(3)
67.583(4)
79.728(3)
791.94(6)
2
isoindol-1-one 7a. A mixture of
3 (255 mg, 1 mmol), 2,2-
)
452.00
Triclinic
P-1
dimethylpropane-1,3-diol (105 mg, 1 mmol), and PTSA (40 mg,
0.2 mmol) in toluene (5 mL) was stirred for 16 h at rt. After cooling,
thesolventwas removed underreduced pressure. Thecrudeproduct
was purified by silicagel chromatography (pentane/EtOAc 6/4, v/v)
to give 7a as a white powder (210 mg, 65%). Rf (heptane/EtOAc 1/1, v/
Crystal system
Space group
ꢁ
a (A)
10.4531(5)
10.6908(5)
11.1744(5)
96.211(2)
103.656(2)
97.933(2)
1188.92(10)
2
ꢁ
b (A)
ꢁ
c (A)
a
b
g
(ꢁ)
(ꢁ)
(ꢁ)
v)¼0.37. Mp¼168 ꢁC. IR (ATR):
n
C]O¼1687 cmꢀ1 1H NMR (CDCl3):
d
¼0.63 (s, 3H, CH3), 0.97 (s, 3H, CH3), 3.17 (d, J¼11.2 Hz,1H, CH2), 3.39
3
ꢁ
V (A )
Z
(d, J¼11.2 Hz, 2H, CH2), 3.68 (d, J¼11.2 Hz,1H, CH2), 4.74 (d, J¼2.1 Hz,
1H, CH(O)2), 5.27 (d, J¼2.1 Hz, 1H, CHeN), 7.24 (t, J¼7.6 Hz, 1H, p-
NePh), 7.52 (m, 6H, o-,m-NePh, H-5, H-6), 7.83 (d, J¼7.6 Hz,1H, H-4),
rcalcd
1.263
0.183
34.75
1.239
0.632
60.63
m
(mmꢀ1
)
7.92 (d, J¼7.6 Hz, 1H, H-7). 13C{1H} NMR (CDCl3):
¼21.5, 22.9, 30.3,
d
Өmax (ꢁ)
63.2, 76.5, 77.6, 98.6, 123.7, 124.1, 124.6, 125.8, 128.6, 129.1, 131.6,
132.9, 137.5, 141.1, 167.8. MS (DCI/NH3): m/z¼324.1 [MH]þ, 341.1
[MþNH4]þ. Elemental anal. Calcd for C20H21NO3: C, 74.28; H, 6.55; N,
4.33; found: C, 74.38; H, 6.52; N, 4.32.
Crystal size (mm)
0.20ꢂ0.20ꢂ0.30
0.20ꢂ0.20ꢂ0.25
ꢁ
l
(A)
0.71073 (MoKa)
1.54180 (CuKa)
Scan mode
T(K)
F
180
58,484
9703
and U scans
F and U scans
180
4795
2372
Refl. measured
Refl. unique
Rint
Refl. with I>3s(I)
Nb. parameters
0.019
8411
298
0.0521
0.0565
ꢀ0.33/0.88
0.026
4126
200
0.0444
0.0305
ꢀ0.26/0.21
4.3.4. 3-(Diethoxymethyl)-2-phenyl-2,3-dihydro-1H-isoindol-1-one
8. A mixture of 3 (255 mg, 1 mmol), triethyl orthoformate (225 mg,
1.5 mmol), in EtOH (5 mL) was refluxed for 4 h. After cooling to
room temperature, ethanol was removed under reduced pressure.
The crude product was purified by silicagel chromatography
(pentane/EtOAc 6/4, v/v) to give 8 as a yellow powder (0.125 g, 40%).
Rf (heptane/EtOAc 1/1, v/v)¼0.4. Mp¼70e71 ꢁC. IR (ATR):
R
Rw
ꢁꢀ3
ꢂ
Residual electron density (e A
)
n
C]O¼1697 cmꢀ1 1H NMR (CDCl3):
¼1.03 (t, J¼6.9 Hz, 3H, CH3),
d
4.3. Synthesis procedures
1.22 (t, J¼6.9 Hz, 3H, CH3), 3.30 (dq, J¼7.0 Hz, J¼2.0 Hz, 1H, CH2),
3.43 (dq, J¼7.0 Hz, J¼2.0 Hz, 1H, CH2), 3.56 (dq, J¼7.0 Hz, J¼2.0 Hz,
1H, CH2), 3.69 (dq, J¼7.0 Hz, J¼2.0 Hz, 1H, CH2), 4.58 (d, J¼4.0 Hz,
1H, CH(O)2), 5.32 (d, J¼4.0 Hz, 1H, CHeN), 7.26 (t, J¼7.5 Hz, 1H, p-
NePh), 7.57 (m, 6H, o-,m-NePh, H-5, H-6), 7.79 (d, J¼7.5 Hz, 1H, H-
4.3.1. 3-Chloro-2-phenyl-2H-isoindole-1-carbaldehyde
3. POCl3
(1.53 g, 10 mmol) was added dropwise to DMF (0.73 g, 10 mmol) at
0 ꢁC. The mixture was stirred for 30 min at room temperature. After
cooling down the solution back to 0 ꢁC, a suspension of 1-
phenylisoindolinone 4 (0.7 g, 3.3 mmol) in DMF (2 mL) was added.
Subsequently, the reaction mixture was heated at 80 ꢁC for 6 h. Then,
after cooling to room temperature, chloroform (10 mL) and ice were
added. The organic layer was collected and the chloroform was re-
moved under reduced pressure. Then, KOH (4 M, 5 mL) and MeOH
(5 mL) were added to the crude residue, and the mixture was stirred
for 1 h at room temperature. The precipitate was filtered, washed
with water, and recrystallized from i-PrOH, to give 3 as a light yellow
4), 7.92 (d, J¼7.5 Hz, 1H, H-7). 13C{1H} NMR (CDCl3):
¼15.0, 15.3,
d
63.4, 64.6, 65.6, 102.7, 123.5, 123.7, 124.8, 125.4, 128.6, 129.0, 131.8,
132.8, 137.9, 168.0. MS (DCI/NH3): m/z¼312.1 [MH]þ, 329.1
[MþNH4]þ. Elemental anal. Calcd for C19H21NO3: C, 73.29; H, 6.80;
N, 4.50; found: C, 73.15; H, 6.57; N, 4.57.
4.3.5. 3-(Ethoxymethylidene)-2-phenyl-2,3-dihydro-1H-isoindol-1-
one 9. The product 9 was isolated by purification on silicagel of the
reaction mixture obtained in the preparation of 8. Rf (heptane/
solid (0.58 g, 69%). Mp¼98e99 ꢁC. IR (ATR):
n
C]O¼1614 cmꢀ1 1H
EtOAc 1/1, v/v)¼0.32. Mp¼136e140 ꢁC. IR (ATR):
n
C]O¼1697 cmꢀ1
NMR (acetone-d6):
d
¼7.36 (t, J¼7.8 Hz,1H, H-5), 7.49 (t, J¼7.8 Hz,1H,
1H NMR (CDCl3):
d
¼1.07, 1.14 (2t, J¼6.9 Hz, 3H, CH3), 3.85, 4.00 (2q,
H-6), 7.72 (m, 6H, H-4, NePh), 8.33 (d, J¼7.8 Hz,1H, H-7), 9.46 (s,1H,
J¼6.9 Hz, 2H, CH2), 6.37, 6.63 (2s, 1H,¼CH), 7.45e8.09 (m, 9H, o-,m-
CHO). 13C{1H} NMR (acetone-d6):
d¼118.6, 120.5, 122.2, 124.4, 128.2,
,p-NePh, H-4, H-5, H-6, H-7).13C{1H} NMR (CDCl3):
d
¼14.7, 59.2,
128.4, 129.4, 130.2, 135.3, 176.1. UVevis: lmax (CHCl3): 379 nm
123.3, 123.7, 124.7, 126.6, 128.1, 129.1, 129.3, 131.7, 132.7, 134.4, 136.1,
¼22,060 L molꢀ1 cmꢀ1). Fluo (lex¼379 nm): lEm¼409 nm. MS (DCI/
137.7, 167.3. MS (DCI/NH3): m/z¼266.1 [MH]þ.
(
3
NH3): m/z¼256.0 [MH]þ. HRMS (DCI/CH4): m/z calcd for
C15H11NOCl: 256.0529; found: 256.0529.
4.3.6. 3-Ethyl-1-(phenylamino)-3,4-dihydro-1H-2-benzopyran-4-
one 13. A EtMgBr solution (0.13 mL, 1 mmol) was added dropwise
to a solution of 3 (255 mg, 1 mmol) in diethylether (15 mL) at
ꢀ78 ꢁC. The reaction mixture was stirred for 1 h at ꢀ78 ꢁS, and then
for 16 h at rt. The mixture was then hydrolyzed with saturated
aqueous NH4Cl, washed with brine, and dried over anhydrous
MgSO4. The solvent was removed under reduced pressure. The
crude product was purified by silicagel chromatography (pentane/
EtOAc 6/4, v/v) to give 13 as a brown solid (94 mg, 35%). Rf (heptane/
EtOAc 1/1, v/v)¼0.31. Mp¼92e93 ꢁC. IR (ATR): nNeH¼3372,
4.3.2. N-(4-methylphenyl)-3-{[(4-methylphenyl)amino]methyl-
idene}-2-phenyl-2,3-dihydro-1H-isoindol-1-imine
hydrochloride
6a. A solution of 3 (255 mg, 1 mmol) and 4-methylaniline (107 mg,
1 mmol) in MeOH (5 mL) was stirred at room temperature for 24 h.
The resulting precipitate was filtered and washed with MeOH
(3ꢂ1 mL) to give 6a as a yellow solid (115 mg, 51%). 1H NMR
(CD3OD):
d
¼2.28 (s, 3H, Me), 2.44 (s, 3H, Me), 6.86 (s, 1H, C]CH),
6.95 (d, J¼8.0 Hz, 2H, Nþ-o-Ar), 7.13 (m, 3H, C]N-m-Ar, N-p-Ph),
7.29e7.35 (m, 5H, eC]N-o-Ar, Nþ-m-Ar), (1H, H-5), 7.66e7.88 (m,
6H, N-o, m-Ph, H-4, H-6), 8.42 (d, J¼8.0 Hz, 1H, H-7). 13C{1H} NMR
n
C]O¼1697 cmꢀ1 1H NMR (CDCl3):
¼1.00, 1.09 (2t, J¼7.5 Hz, 3H,
d
CH3), 1.86e2.22 (m, 2H, CH2), 4.25, 4.45 (2m, 1H, CH(C]O)), 4.59,
4.62 (2m, 1H, NH), 6.22 (m, 1H, CHeN), 6.88e6.98 (m, 3H, o-,p-
(CD3OD):
d
¼19.3, 19.7, 116.3, 121.2, 121.3, 124.4, 126.1, 126.6(2c),